EXI3:F:F-iShares Dow Jones Industrial Average UCITS ETF (DE) (EUR)

ETF | Others |

Last Closing

USD 350.95

Change

-17.25 (-4.68)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-04 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SXR8:F iShares Core S&P 500 UCITS ETF..

-23.14 (-4.44%)

USD 108.00B
UIM5:F UBS (Lux) Fund Solutions - MSC..

-2.49 (-5.24%)

USD 105.67B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

-2.60 (-4.98%)

USD 104.83B
XDNY:F Xtrackers MSCI Japan ESG Scree..

-0.75 (-5.30%)

USD 62.86B
VUSA:F Vanguard Funds Public Limited ..

N/A

USD 51.63B
SXRZ:F iShares VII PLC - iShares Nikk..

-10.10 (-4.76%)

USD 49.04B
XJSE:F Xtrackers II - Japan Governmen..

+0.06 (+0.82%)

USD 41.48B
0ZC:F Zscaler Inc

-12.68 (-7.25%)

USD 37.92B
BSND:F Danone SA

+0.50 (+3.60%)

USD 33.83B
VGWL:F Vanguard FTSE All-World UCITS ..

N/A

USD 24.77B

ETFs Containing EXI3:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -13.57% 21% F 38% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -13.57% 20% F 37% F
Trailing 12 Months  
Capital Gain -1.67% 43% F 56% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -1.67% 40% F 48% F
Trailing 5 Years  
Capital Gain 79.73% 68% D+ 65% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 79.73% 68% D+ 48% F
Average Annual (5 Year Horizon)  
Capital Gain 12.98% 78% C+ 70% C-
Dividend Return 12.98% 76% C+ 62% D
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 10.81% 63% D 89% A-
Risk Adjusted Return 120.04% 97% N/A 97% N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike